Europe Arthroscopy Devices Market Size

Europe Arthroscopy Devices Market Analysis

The Europe Arthroscopy Devices Market size is estimated at USD 382.38 million in 2024, and is expected to reach USD 432.21 million by 2029, growing at a CAGR of 2.48% during the forecast period (2024-2029).

• COVID-19 has presented unexpected challenges to healthcare institutions worldwide and had an impact on European healthcare institutions. This virus also impacted the European arthroscopy devices market. For instance, an article published by the European Federation of National Associations of Orthopaedics and Traumatology (EFORT), in February 2022, reported that the COVID-19 pandemic led to the near-total shutdown of total joint arthroplasty surgeries in Europe. The source also reported that arthroplasty surgeries in Europe decreased by 28.7% in 2020 compared to the previous year. Only life-threatening pathologies like periprosthetic fractures and acute septic arthroplasty had undergone surgical treatment. Thus, the cancellation and postponement of arthroplasty surgical procedures in Europe have impacted the growth of the studied market. In the current, as the government restriction became flexible with a decrease in the number of COVID-19 cases, the number of surgical procedures performed in Europe has increased compared to the beginning of the pandemic, and thus the market is expected to witness significant growth over the forecast period.
• The factors that are driving the growth of this market are increasing incidences of sports injuries, a rising geriatric population, and technological advancements in arthroscopic implants.
• The incidence of sports injuries has increased over the last few years, primarily due to the growing participation in sports as well as active participation in fitness activities. For instance, an article published in the journal Sec. Injury Prevention and Rehabilitation, in June 2021, reported that the 1-year prevalence of a severe sports injury episode was 31%. The most common injury locations for these injuries were the knee (25%), ankle (20%), and hip/groin (15%). The prevalence of an ongoing injury episode was 19%. Thus, the large number of sports-related injuries is increasing the demand for arthroplasty services, thereby fueling the growth of the market studied.
• Furthermore, the technological advancements in arthroscopic implants are another reason for fuelling the growth of the market in the region. For instance, in June 2022, NGMedical GmbH, a medical device manufacturer exclusively focused on creating innovative technologies for spinal applications, launched its new product, ART Fixation System, in Europe. Similarly, in May 2021, Safe launched the CE marking of Sycamore, an implant designed to secure the treatment of vertebral fractures and reduce the risk of adjacent fractures. Thus, such product launches are driving the growth of the studied market.
• European countries have a large section of geriatric population in their total population. The population aged 65 years and above is highly prevalent in arthroplasty surgeries. For instance, in July 2022, United Nations Projection reported that 9.6 million population in Spain aged above 65 years in the year 2022, and this population is expected to increase to 11.4 million by 2030 and to 13.8 million in 2040. Thus, a high number of arthroscopic surgeries among the increasing number of geriatric individuals is driving the growth of the studied market.
• Thus, due to the increasing incidences of sports injuries, a rising geriatric population, and technological advancements in arthroscopic implants, the market is expected to witness significant growth over the forecast period. However, the lack of skilled surgeons and stringent regulatory requirements may slow the growth of the market over the forecast period.